9 September 2022

Gavi Vaccine Investment Strategy Steering Committee is now open for applications

The VIS Steering Committee will be convened to provide expert advice across multiple perspectives and deliberations and will provide technical input into the development of Gavi Secretariat’s recommendations to the Programme and Policy Committee…

5 September 2022

Call for Applications: COVAX seeks experts for independent group on evidence-based vaccine decision-making

The COVAX Facility is seeking expressions of interest from the subject matter experts to join the COVAX Independent Product Group. The Independent Product Group (“IPG”) is established to provide scientific advice on COVID-19 vaccines and make…

22 August 2022

Nigeria launches major push to protect millions of children against deadliest form of diarrhoeal disease

Today’s launch marks the introduction of the rotavirus vaccine, which protects against rotavirus-related diarrhoeal disease, into Nigeria’s routine immunisation programme.

5 August 2022

Republic of the Congo to vaccinate more than 4 million people against yellow fever

The preventive mass vaccination campaign will target nearly the entire population, ranging from 9 months to 60 years old in 11 departments in Congo.

29 July 2022

Immunisation in lower-income countries: pandemic leads to decline in coverage, but signs of recovery emerge

New analysis of the state of routine immunisation in lower-income countries underlines impact of COVID-19 pandemic, but signs of recovery are emerging.

29 July 2022

Global monkeypox outbreak underlines need for vigilance, engagement and solidarity with partners, countries and civil society

The escalating global monkeypox outbreak has affected over 18,000 people in 78 countries, across all World Health Organization (WHO) regions. This unprecedented spread has led the WHO Director-General to declare the escalating outbreak a Public…

20 July 2022

Gavi opens applications for malaria vaccine rollout support

Gavi is opening its first application window for support in rolling out the first ever malaria vaccine, to protect children against a disease that kills hundreds of thousands in Africa.

13 July 2022

Gavi continues to be a top performer in global aid transparency index

Gavi ranked in the highest category out of 50 international development organisations assessed in the 2022 Aid Transparency Index.

24 June 2022

Gavi board responds to an uncertain world: fragile and conflict settings, future pandemics and the ongoing fight against COVID-19

Gavi’s Board Meeting emphasizes public health impact with renewed push for routine immunization and reaching zero-dose children.

21 June 2022

Gavi launches new partnership to reach “zero-dose” children across marginalised communities

At least 12.4 million children worldwide are categorised as “zero-dose”,  living in missed communities that cannot access many essential services, including health care.

19 May 2022

COVAX calls for urgent action to close vaccine equity gap

COVAX has access to enough COVID-19 vaccines to help protect 70% of the population in 91 lower-income countries

12 May 2022

DFC financing up to US$ 1 billion for Gavi COVID-19 vaccine and ancillary supply purchase and delivery

The White House today announced that US International Development Finance Corporation (DFC) and Gavi, the Vaccine Alliance have partnered to create the COVAX Rapid Financing Facility, which will provide up to US$ 1 billion to accelerate COVID-19…

Last updated: 25 Feb 2021

Subscribe to our newsletter